Developing Cancer Treatments is HARD! But, is everyone bad at it?
Historically speaking, Oncology
the development has been particularly fraught with failure:
“Specializing
Matters?”
Big players aren’t all created equally
Some companies are having more success in
Oncology than other Diseases:
Abbvie, Takeda, Roche/Genetech, Merck,
Pfizer and Bristol-Myers-Squibb
Read more...